- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.04. | BioCorRx Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.04. | BioCorRx receives new patent for novel compound to treat pain, depression, and schizophrenia | 1 | Seeking Alpha | ||
| 03.04. | BioCorRx Inc: BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia | 218 | GlobeNewswire (Europe) | ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer of innovative treatment programs for substance use and related disorders... ► Artikel lesen | |
| 01.04. | BioCorRx Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 28.02. | BioCorRx Inc: BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD | 158 | GlobeNewswire (Europe) | ANAHEIM, CA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance use and related... ► Artikel lesen | |
| 08.02. | BioCorRx Inc: BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors | - | GlobeNewswire (USA) | ||
| 09.01. | BioCorRx Inc: BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President | 1 | GlobeNewswire (USA) | ||
| 05.01. | BioCorRx Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.12.23 | BioCorRx Inc. - 8-K, Current Report | - | SEC Filings | ||
| 16.11.23 | BioCorRx Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.11.23 | BioCorRx Inc: BioCorRx Reports Business Update for the Third Quarter of 2023 | 430 | GlobeNewswire (Europe) | ANAHEIM, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related... ► Artikel lesen | |
| 14.11.23 | BioCorRx Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08.23 | BioCorRx Inc: BioCorRx Reports Business Update for the Second Quarter of 2023 | 499 | GlobeNewswire (Europe) | On Track to Meet 2023 Regulatory Milestones ANAHEIM, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment... ► Artikel lesen | |
| 16.05.23 | BioCorRx Inc: BioCorRx Provides Business Update for the First Quarter of 2023 | 455 | GlobeNewswire (Europe) | Revenue Increases 97% ANAHEIM, CA, May 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 51,20 | -1,73 % | EQS-DD: Siemens Healthineers AG: Dr. Bernhard Montag, Kauf von Siemens Healthineers Aktien für einen Betrag von EUR 98.817,91 abzüglich Steuern und Abgaben als automatische Wiederanlage von ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
26.04.2024 / 14:49... ► Artikel lesen | |
| FRESENIUS | 27,970 | 0,00 % | Fresenius-Aktie leicht im Minus (27,10 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Fresenius zur Stunde im Minus. Der jüngste Kurs betrug 27,10 Euro. Heute hat sich an der deutschen Börse der Anteilsschein von Fresenius zwischenzeitlich... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,200 | +1,52 % | Aixtron, FMC, LPKF Laser, ProSiebenSat.1 Media, Siemens Energy, Varta und Co. - Aktien-Positionen der Shortseller | Wer Aktien leer verkauft, das sogenannte Shortselling, muss Transparenzpflichten erfüllen. Wir werfen einen Blick auf aktuelle Shortseller-Meldungen. Geregelt sind diese in der EU-Leerverkaufsverordnung... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS | 22,090 | +3,08 % | Mobile-health Retreats on Opening New Pharmacy | ||
| GERRESHEIMER | 101,60 | +0,59 % | Neue 14,00% Aktienanleihe mit Barriere auf Gerresheimer in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NGZ8/ WKN VD4NGZ) mit Barriere auf die Aktie von Gerresheimer... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 97,35 | -1,77 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
| ATRICURE | 22,210 | -10,48 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 61,69 | +1,78 % | Earnings call: PROCEPT BioRobotics sees 83% revenue surge in Q1 2024 | ||
| RXSIGHT | 59,63 | +5,11 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| AGILITI | 10,070 | -0,35 % | DigitalOcean to replace Agiliti in S&P SmallCap Index | ||
| PRIVIA HEALTH GROUP | 18,410 | +2,28 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 11,060 | +4,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 32,070 | -0,65 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| GENEDX | 19,490 | -6,66 % | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
| ADAPTHEALTH | 10,350 | +2,88 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen |
BIOCORRX INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
